AstraZeneca plans new pivotal lung cancer trial with Incyte

LONDON (Reuters) - AstraZeneca is stepping up its bet on immunotherapy combination treatments to fight lung cancer by signing a deal with Incyte under which the two companies will start a final-stage Phase III clinical trial next year.

from Reuters: Health News http://ift.tt/2zSglgI